Oliver Maier

Head of Investor Relations at Bayer AG

Oliver Maier

Oliver Maier

Head of Investor Relations at Bayer AG

Biography

Currently, Oliver Maier occupies the position of Head-Investor Relations at Bayer AG and Head-Investor Relations & Corporate Communications at Fresenius Medical Care Holdings, Inc. In his past career he occupied the position of Head-Investor Relations at Fresenius Medical Care AG & Co. KGaA.

Overview
RelSci Relationships

1042

Birthday

1966

Age

53

Relationships
RelSci Relationships are individuals Oliver Maier likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Fresenius Medical Care AG & Co. KGaA

Relationship likelihood: Strong

Head, Crop Science Division at Bayer AG

Relationship likelihood: Strong

Chief Executive Officer at Bayer AG

Relationship likelihood: Strong

Chief Financial Officer at Fresenius Medical Care AG & Co. KGaA

Relationship likelihood: Strong

Head of Communications Crop Science at Bayer AG

Relationship likelihood: Strong

Chief Executive Officer at Fresenius Medical Care Holdings, Inc.

Relationship likelihood: Strong

Director at Fresenius Medical Care Holdings, Inc.

Relationship likelihood: Strong

Head, EMEA at Fresenius Medical Care Holdings, Inc.

Relationship likelihood: Strong

Head of Diabetes & Cardiovascular at Sanofi

Relationship likelihood: Strong

Head of Product Media Relations at Bayer AG

Relationship likelihood: Strong

Paths to Oliver Maier
Potential Connections via
Relationship Science
You
Oliver Maier
Head of Investor Relations at Bayer AG
Career History
Head of Investor Relations
Current

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal year 2012, Bayer employed 110,500 people and had sales of €39.8 billion. Capital expenditures amounted to €2 billion, R&D expenses to €3 billion.

Head-Investor Relations & Corporate Communications
Current

Fresenius Medical Care Holdings, Inc. provides kidney dialysis services and renal care products. It offers specialty pharmacy and laboratory services as well as manufacturing and distributing dialysis equipment, disposable products, and renal pharmaceuticals. The company was founded in 1996 and is headquartered in Waltham, MA.

Senior Vice President & Head of Investor Relations & Corporate Communications
Prior - 2017

Fresenius Medical Care AG & Co. KGaA provides products and services for patients with chronic kidney failure. The company's products include dialysis machines, dialyzers and related disposables. It also offers renal information technology solutions and provides services such as renal replacement therapy and therapeutic apheresis. Fresenius Medical Care was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Oliver Maier. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Oliver Maier's profile does not indicate a business or promotional relationship of any kind between RelSci and Oliver Maier.